Skip to content

Released Aug 10, 2016, before the open

10-Q filed Aug 10, 2016, 41 days after period end · 0001193125-16-677550

Q2 2016 · 10-Q
Revenue—
Net Income-$8.68MN/M vs Q2 2015N/M vs Q1 2016
EPS Diluted-$0.33N/M vs Q2 2015N/M vs Q1 2016
Operating Income-$8,780,000N/M
Operating Cash Flowderived-$8,003,000N/M
Free Cash Flowderived-$8,224,000—

What the release said

The release

Same quarter

MetricQ2 2016Q2 2015Q2 2014
Net Income-$8.68M-$2.39M-$2.85M
EPS Diluted-$0.33-$0.15-$3.81

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Rocket Pharmaceuticals, Inc. · CIK 1281895 · Engraved from SEC EDGAR